Assessing biosafety using NGS-based tests requires a continuum of skills in molecular biology, biocomputing, virology, and quality systems.
Audrey Brussel
Advertisement
Audrey Brussel, PhD, audrey.brussel@pathoquest.com, is Viral Safety leader at PathoQuest.
Articles by Audrey Brussel
Advertisement
Latest Updated Articles
Challenges When Outsourcing Viral Safety ServicesPublished: May 16th 2021 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
2
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
3
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
4
